Telik Announces Preliminary Agreement on Design of Phase 3 Registration Trial of Telintra® in Low to Intermediate-1 Risk Myelodysplastic Syndrome

[at noodls] – TELIK ANNOUNCES PRELIMINARY AGREEMENT ON DESIGN OF PHASE 3 REGISTRATION TRIAL OF TELINTRA® IN LOW TO INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROME Palo Alto, CA – January 22, 2013 – Telik, Inc. (Nasdaq: … more

View todays social media effects on TELK

View the latest stocks trending across Twitter. Click to view dashboard

See who Telik is hiring next, click here to view